Correction: Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis.

IF 5.1 2区医学 Q1 RHEUMATOLOGY

RMD Open Pub Date : 2024-11-21 DOI:10.1136/rmdopen-2024-004480corr1

引用次数: 0

查看原文本刊更多论文

更正：类风湿性关节炎患者使用抗肿瘤坏死因子多价 VHH 抗体 ozoralizumab 的长期安全性和有效性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

RMD Open RHEUMATOLOGY-

CiteScore

7.30

自引率

6.50%

发文量

205

审稿时长

14 weeks

期刊介绍： RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.